Breast cancer: Epidemiology, risk factors, screening;CANCER DU SEIN: EPIDEMIOLOGIE, FACTEURS DE RISQUE, DEPISTAGE

Revue du Praticien

Volumn 48, Issue 1, 1998, Pages 21-27

  Gairard, Béatrice ^a   Mathelin, Carole ^a   Schaffer, Paul ^b   Brettes, Jean Philippe ^a  

^a Hopital Central Strasbourg   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BREAST CANCER; CHEMOPROPHYLAXIS; CONTRACEPTION; FEMALE; FRANCE; HEREDITY; HISTOLOGY; HORMONE BLOOD LEVEL; HUMAN; INCIDENCE; IRRADIATION; MAMMOGRAPHY; MENOPAUSE; MORBIDITY; MORTALITY; NUTRITION; PREVENTIVE MEDICINE; PRIMARY PREVENTION; RISK FACTOR; SECONDARY PREVENTION; SURVIVAL TIME; ADULT; AGED; BREAST TUMOR; HEALTH SURVEY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; REVIEW; RISK; SURVIVAL;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FRANCE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; RISK; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0031610607     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Schaffer P, Rezvani A. Cancer du sein: incidence, mortalité, survie, tendances évolutives. Rev Fr Laboratoires 1996; 286: 123-8.
2. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: 146-51.
3. Dupont WD, Page DL Breast cancer risk associated with proliferative disease, age at first birth and a family history of breast cancer. Am J Epidemiol 1987; 125: 769-79.
4. Adami HO, Bergstrom R, Hansen J. Age at first primary as a determinant of the incidence of bilateral breast cancer. Cancer 1985; 55: 643-7.
5. Renaud R, Gairard B, Bellocq JP, Rouyer N, Barrios C Risque de récidives locales, ganglionnaires et métastatiques en fonction des facteurs de pronostic et du temps. In: Sous la direction de Bremond A. Cancer du sein. Surveillance après traitement. Lyon, Méditions : 1991; 1-36.
6. Schottenfeld D, Berg J. Incidence of multiple primary cancer. IV Cancer of the female breast and genital organs. J Natl Cancer Inst 1971; 46: 161-70.
7. Collaborative group on hormonal factors in breast cancer. Breast cancer and hormonal contraceptives: further results. Contraception 1996; 35: 1-106.
8. Colditz GA, Hankinson SE, Hunter DJ et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-93.
9. Prentice RL, Pepe M, Self SG. Dietary fat and breast cancer : a qualitative assessment of the epidemiological literature and a discussion of methodological issues. Cancer Res 1989; 49: 3147-56.
10. Ritter MM, Richter WO. Effects of a vegetarian life style on health. Fortschr Med 1995; 113 (16): 239-42.
11. Kuller LH. The etiology of breast cancer - from epidemiology to prevention. Public Health Rev 1995; 23 (2): 157-213.
12. Ewertz M. Breast cancer in Denmark. Incidence, risk factors, and characteristics of survival. Acta Oncol 1993; 32 (6): 595-615.
13. Fuchs CS, Stampfer MJ, Colditz GA et al. Alcohol consumption and mortality among women. N Engl J Med 1995; 332 (19): 1245-50.
14. Colditz GA Epidemiology of breast cancer. Findings from the nurses' health study. Cancer 1993; 71 (suppl 4): 1480-9.
15. Grady DG, Ernster VL. The role of methylxanthines in the epidemiology of benign and malignant breast disease. In: Gundfest-Broniatowski S, Esselstyn CB (eds). Controversies in breast disease: diagnosis and management. New York: Marcel Dekker, 1988: 91-107.
16. Mauch PM, Kalish LA, Marcus KC et al. Second malignancies after treatment of laparotomy aged IA-IIIB Hodgkin's disease : long-term analysis of risk factors and outcome. Blood 1996; 87 (9): 3625-32.
17. Mettler FA, Upton AC, Kelsey CA, Ashby RN, Rosenberg RD, Linver MN. Benefits versus risks from mammography : a critical reassessment. Cancer 1996; 77 (5): 903-9.
18. Hrubec Z, Boice JD, Monson RR, Rosenstein M. Breast cancer after multiple chest fluoroscopies : second follow-up of Massachusetts women with tuberculosis. Cancer Res 1989; 49: 229-34.
19. Tokunaga M, Land LE, Yamamoto T et al. Breast cancer among atomic bomb survivors. In : Boice JD, Fraument JF (eds). Radiation carcinogenesis : Epidemiology and biological significance. New York: Raven Press, 1984: 45-56.
20. Dupont WD, Page DL Rogers LW, Pari FF. Influence of exogenous estrogens, proliferative breast disease and other variables on breast cancer risk. Cancer 1989; 63: 948-57.
21. Hilakivi-Clarke L, Rowland J, Clarke R, Lippman ME. Psychosocial factors in the development and progression of breast cancer. Breast Cancer Res Treat 1994; 29 (2): 141-60.
22. Patavino VM, Epifani AC, Avena C, Minelli L. Epidemiology of breast carcinoma. Ann Ig 1995; 7 (4): 257-66.
23. Van Loon AJ, Brug J, Goldbohm RA, Van Den Brandt PA, BrugJ. Differences in cancer incidence and mortality among socioeconomic groups. Scand J Soc Med 1995; 23(2): 110-20.
24. Soutoul JH, Pierre F, Magnin G. Le sein féminin objet de plaintes en responsabilité. Analyse de la jurisprudence. J Gynecol Obstet Biol Reprod 1987; 16:841-50.
25. Mack TM, Henderson BE, Gerkins VR et al. Reserpine and breast cancer in a retirement community. N Engl J Med 1975; 292: 1366.
26. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis : xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 1993; 101 (5): 372-7.
27. Cantor KP, Stewart PA, Brinton LA, Dosemeci M. Occupational exposures and female breast cancer mortality in the United States. J Occup Environ Med 1995; 37 (3): 336-48.
28. Renaud R, Gairard B, Schaffer P, Haehnel P, Dale G. Définition: et principes du dépistage du cancer du sein. In: Lansac J, Lefloch O, Bougnoux Ph (eds). Dépistage du cancer du sein et conséquences thérapeutiques. Paris: Masson, 1989: 1-15.
29. Wald NJ, Chamberlain J, Hackshaw A. Report of the European Society for Mastology. Breast cancer screening evaluation committee. Breast 1993; 2: 209-16.
30. Fletcher S. Breast cancer screening in women aged under 50. BMJ 1997; 314: 764-5.
31. Allemand H. Dépistage de masse du cancer du sein. Expériences pilotes du Fonds national de prévention, d'éducation et d'information sanitaires. In: Sancho Garnier H, Béraud C, Dore JF, Pierret J, Schaffer P (eds). Paris : INSERM, 1997 : 29-37.
32. Renaud R. Le dépistage systématique du cancer du sein doit-il être étendu à l'ensemble du territoire ? La France n'est pas encore prête pour un dépistage national. Rev Prat (Paris) 1997; 47: 237-40.